Physician

Roopen R Patel, MD

According to 2025 Medicare claims, Roopen Patel, MD (NPI: 1528145224) practices allergy/immunology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is CAROLINA ASTHMA AND ALLERGY CENTER PA (NPI: 1215995444; TIN: 561227652) and primary practice location at 29732-1091.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 210 traditional Medicare patients, billed 21,798 HCPCS/CPT codes, and received $391,112 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,193 prescription claims across 253 beneficiaries totaling $1,444,716 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 318 claims. Open Payments data shows 142 records totaling $49,244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $63,728 to $391,112. Similarly, Part D prescription costs have moved sharply higher in recent years, from $70,317 to $1,444,716. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $3,982 to $9,453.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	180	8,251	$63,728
2016	163	7,386	$71,206
2017	169	10,437	$156,142
2018	185	15,630	$294,266
2019	202	20,971	$385,237
2020	178	20,599	$412,901
2021	213	21,340	$420,305
2022	198	16,640	$327,721
2023	219	19,910	$358,400
2024	210	21,798	$391,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	127	524	$70,317
2016	134	653	$115,736
2017	127	636	$114,820
2018	164	852	$177,963
2019	164	752	$298,655
2020	172	840	$372,199
2021	169	782	$411,204
2022	190	826	$664,628
2023	228	938	$1,200,727
2024	253	1,193	$1,444,716

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	53	$111,153
2016	N/R	56	$142,520
2017	N/R	75	$73,993
2018	N/R	102	$125,793
2019	N/R	138	$156,181
2020	N/R	242	$309,948
2021	N/R	269	$359,249
2022	N/R	309	$469,461
2023	N/R	256	$427,135
2024	33	318	$524,419

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	144	$86
95165	Professional service for preparation and provision of 1 or more antigens	65	1,660	$10
95117	Professional service for multiple injections of allergen	50	998	$8
95004	Test for allergy using allergenic extract	60	4,317	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	43	1,206	$413,747
Xolair	Omalizumab	121	3,388	$355,546
Dupixent Pen	Dupilumab	59	1,652	$217,279
Nucala	Mepolizumab	18	504	$140,048
Dupixent Syringe	Dupilumab	12	378	$51,092

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	11	97	$445,809
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	13	$70,731
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	11	97	$6,320
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	11	86	$906
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$473

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$49,244	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roopen R. Patel, MD?

Tedicare shows public-source Medicare data for Roopen R. Patel, MD (NPI 1528145224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roopen R. Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Roopen R. Patel, MD?

Roopen R. Patel, MD is linked to CAROLINA ASTHMA AND ALLERGY CENTER PA (billing NPI 1215995444) in the available physician profile data.

Does Roopen R. Patel, MD have Open Payments data?

Roopen R. Patel, MD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.